David H. Rominger

2.8k total citations · 2 hit papers
18 papers, 2.0k citations indexed

About

David H. Rominger is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David H. Rominger has authored 18 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David H. Rominger's work include Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (7 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). David H. Rominger is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (7 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). David H. Rominger collaborates with scholars based in United States, Italy and China. David H. Rominger's co-authors include Jonathan D. Violin, Scott M. DeWire, Dennis S. Yamashita, Michael W. Lark, Conrad L. Cowan, Michael Koblish, Philip Pitis, Catherine Yuan, Dimitar B. Gotchev and Xiaotao Chen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and British Journal of Cancer.

In The Last Decade

David H. Rominger

18 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine

2013 502 citations Scott M. DeWire, Dennis S. Yamashita et al. Journal of Pharmacology and Experimental Therapeutics profile →
Quantifying Ligand Bias at Seven-Transmembrane Receptors

2011 306 citations Sudarshan Rajagopal, Seungkirl Ahn et al. Molecular Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David H. Rominger United States	15	1.6k	1.2k	227	205	193	18	2.0k
Conrad L. Cowan United States	18	1.3k 0.8×	946 0.8×	495 2.2×	157 0.8×	285 1.5×	21	1.9k
Paul Leff United Kingdom	16	1.8k 1.1×	1.2k 1.0×	280 1.2×	102 0.5×	304 1.6×	26	2.6k
Robert H. Stoffel United States	17	1.6k 1.0×	741 0.6×	190 0.8×	53 0.3×	196 1.0×	21	2.0k
Hervé Paris France	21	1.0k 0.7×	621 0.5×	271 1.2×	72 0.4×	105 0.5×	43	1.5k
James W. Wisler United States	11	1.1k 0.7×	622 0.5×	129 0.6×	129 0.6×	151 0.8×	18	1.3k
A. Thomsen United States	17	1.1k 0.7×	595 0.5×	103 0.5×	81 0.4×	153 0.8×	32	1.5k
Bianca Plouffe Canada	19	1.1k 0.7×	587 0.5×	111 0.5×	91 0.4×	346 1.8×	34	1.5k
Gina H. Lu United States	21	1.1k 0.7×	388 0.3×	180 0.8×	105 0.5×	371 1.9×	32	2.0k
Margot W. Beukers Netherlands	27	1.0k 0.6×	418 0.4×	103 0.5×	87 0.4×	77 0.4×	42	1.9k
Mireille Hogue Canada	21	1.6k 1.0×	854 0.7×	140 0.6×	74 0.4×	134 0.7×	29	2.4k

Countries citing papers authored by David H. Rominger

Since Specialization

Citations

This map shows the geographic impact of David H. Rominger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Rominger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Rominger more than expected).

Fields of papers citing papers by David H. Rominger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Rominger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Rominger. The network helps show where David H. Rominger may publish in the future.

Co-authorship network of co-authors of David H. Rominger

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Rominger. A scholar is included among the top collaborators of David H. Rominger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Rominger. David H. Rominger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Koblish, Michael, Richard W. Carr, Edward R. Siuda, et al.. (2017). TRV0109101, a G Protein-Biased Agonist of the µ-Opioid Receptor, Does Not Promote Opioid-Induced Mechanical Allodynia following Chronic Administration. Journal of Pharmacology and Experimental Therapeutics. 362(2). 254–262. 27 indexed citations

Siuda, Edward R., Richard W. Carr, David H. Rominger, & Jonathan D. Violin. (2016). Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics. Current Opinion in Pharmacology. 32. 77–84. 109 indexed citations

Strachan, Ryan T., Jin‐Peng Sun, David H. Rominger, et al.. (2014). Divergent Transducer-specific Molecular Efficacies Generate Biased Agonism at a G Protein-coupled Receptor (GPCR). Journal of Biological Chemistry. 289(20). 14211–14224. 101 indexed citations

Rominger, David H., Conrad L. Cowan, William Gowen-MacDonald, & Jonathan D. Violin. (2014). Biased ligands: pathway validation for novel GPCR therapeutics. Current Opinion in Pharmacology. 16. 108–115. 25 indexed citations

DeWire, Scott M., Dennis S. Yamashita, David H. Rominger, et al.. (2013). A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine. Journal of Pharmacology and Experimental Therapeutics. 344(3). 708–717. 502 indexed citations breakdown →

Chen, Xiaotao, Philip Pitis, Guodong Liu, et al.. (2013). Structure–Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the Treatment of Acute Severe Pain. Journal of Medicinal Chemistry. 56(20). 8019–8031. 172 indexed citations

Rajagopal, Sudarshan, Seungkirl Ahn, David H. Rominger, et al.. (2011). Quantifying Ligand Bias at Seven-Transmembrane Receptors. Molecular Pharmacology. 80(3). 367–377. 306 indexed citations breakdown →

Violin, Jonathan D., Scott M. DeWire, Dennis S. Yamashita, et al.. (2010). Selectively Engaging β-Arrestins at the Angiotensin II Type 1 Receptor Reduces Blood Pressure and Increases Cardiac Performance. Journal of Pharmacology and Experimental Therapeutics. 335(3). 572–579. 300 indexed citations

Violin, Jonathan D., David G. Soergel, Scott M. DeWire, et al.. (2010). TRV120027, a β-Arrestin Biased Ligand at the Angiotensin II Type 1 Receptor, Produces Unique Pharmacology and Is a Novel Potential Therapy for Heart Failure. Journal of Cardiac Failure. 16(8). S72–S72. 2 indexed citations

10.

Kumar, Rakesh, et al.. (2009). Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors. British Journal of Cancer. 101(10). 1717–1723. 177 indexed citations

11.

Rominger, Cynthia M., Robert A. Copeland, Elizabeth A. Davenport, et al.. (2009). Evidence for Allosteric Interactions of Antagonist Binding to the Smoothened Receptor. Journal of Pharmacology and Experimental Therapeutics. 329(3). 995–1005. 52 indexed citations

12.

Minthorn, Elisabeth A., Thomas Mencken, Andrew G. King, et al.. (2008). Pharmacokinetics and Brain Penetration of Casopitant, a Potent and Selective Neurokinin-1 Receptor Antagonist, in the Ferret. Drug Metabolism and Disposition. 36(9). 1846–1852. 23 indexed citations

13.

Zhang, Ge, Ning Huang, Yu-Wen Li, et al.. (2003). Pharmacological Characterization of a Novel Nonpeptide Antagonist Radioligand, (±) -N-[2-Methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1 H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for Corticotropin-Releasing Factor1 Receptors. Journal of Pharmacology and Experimental Therapeutics. 305(1). 57–69. 23 indexed citations

14.

Zaczek, Robert, Robert J. Chorvat, J Saye, et al.. (1998). Two New Potent Neurotransmitter Release Enhancers, 10,10-Bis(4-Pyridinylmethyl)-9(10H)-Anthracenone and 10,10-Bis(2-Fluoro-4-Pyridinylmethyl)-9(10H)-Anthracenone: Comparison to Linopirdine. Journal of Pharmacology and Experimental Therapeutics. 285(2). 724–730. 115 indexed citations

15.

Rominger, David H., Cynthia M. Rominger, Lawrence W. Fitzgerald, et al.. (1998). Characterization of [125I]Sauvagine Binding to CRH2 Receptors: Membrane Homogenate and Autoradiographic Studies. Journal of Pharmacology and Experimental Therapeutics. 286(1). 459–468. 53 indexed citations

16.

Watanabe, Mizuki, David H. Rominger, Stephen D. Hurt, E B De Souza, & S. William Tam. (1993). [3H]1-(cyclopropylmethyl)-4-(2-(4-fluorophenyl)-2-oxoethyl) piperidine HBr (DuP 734). A selective ligand for sigma receptors in mouse brain in vivo.. Journal of Pharmacology and Experimental Therapeutics. 266(3). 1541–1548. 6 indexed citations

17.

Culp, Steven, David H. Rominger, S. William Tam, & E B De Souza. (1992). [3H]DuP 734 [1-(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'- oxoethyl)-piperidine HBr]: a receptor binding profile of a high-affinity novel sigma receptor ligand in guinea pig brain.. Journal of Pharmacology and Experimental Therapeutics. 263(3). 1175–1187. 12 indexed citations

18.

Tam, See‐Ying, David H. Rominger, & Victor J. Nickolson. (1991). Novel receptor site involved in enhancement of stimulus-induced acetylcholine, dopamine, and serotonin release.. Molecular Pharmacology. 40(1). 16–21. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact